The deal range was $2.00-$2.20. Leerink and Piper Sandler acted as joint book running managers for the offering.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AKBA:
- Closing Bell Movers: Five Below up 10% after Q4 beat
- Akebia announces common stock offering, no amount given
- Akebia Therapeutics’ Strong Market Performance and Strategic Initiatives Drive Buy Rating
- Akebia price target raised to $6 from $4 at Piper Sandler
- Akebia Therapeutics Faces Global Regulatory Challenges Amid Brexit and EU Changes
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue